1. Carrying out local care for epidermal necrolysis: survey of practices. (7th October 2020) Authors: Ingen‐Housz‐Oro, S.; Le Floch, R.; Alves, A.; Colin, A.; Ouedraogo, R.; Welfringer, A.; Dereure, O.; Besnard, N.; Bodemer, C.; Bernier, C.; Hoffmann, C.; Tétart, F.; Carpentier, D.; Cordel, N.; Elie, E.; Tauber, M.; Soubiron, L.; Milpied, B.; de Prost, N. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 2(2021) Page Start: e155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Childhood epidermal necrolysis and erythema multiforme major: a multicentre French cohort study of 62 patients. (21st July 2021) Authors: Giraud‐Kerleroux, L.; Bellon, N.; Welfringer‐Morin, A.; Leclerc‐Mercier, S.; Costedoat, I.; Coquin, J.; Brun, A.; Roguedas‐Contios, A.‐M.; Bernier, C.; Milpied, B.; Tétart, F.; Du Thanh, A.; Cordel, N.; Bensaid, B.; Fargeas, C.; Tauber, M.; Renolleau, S.; Boralevi, F.; Ingen‐Housz‐Oro, S.; Bodeme... Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 10(2021) Page Start: 2051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Immunomodulatory and/or immunosuppressive drugs should not be stopped prior to skin tests for the assessment of drug allergy. (1st April 2022) Authors: Dezoteux, F.; El Mesbahi, S.; Tedbirt, B.; Grosjean, J.; Gautier, S.; Lannoy, D.; Nassar, C.; Tétart, F.; Staumont‐Sallé, D. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Immunomodulatory and/or immunosuppressive drugs should not be stopped prior to skin tests for the assessment of drug allergy. (23rd January 2022) Authors: Dezoteux, F.; El Mesbahi, S.; Tedbirt, B.; Grosjean, J.; Gautier, S.; Lannoy, D.; Nassar, C.; Tétart, F.; Staumont‐Sallé, D. Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 742 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice. (1st April 2022) Authors: Marniquet, M.‐E.; Seneschal, J.; Darrigade, A.‐S.; Staumont‐Sallé, D.; Jachiet, M.; Nosbaum, A.; Tauber, M.; Abasq, C.; Ferrier Le Bouedec, M.‐C.; Droitcourt, C.; Aubert, H.; Bernier, C.; Soria, A.; Raison‐Peyron, N.; Tétart, F.; Aubin, F.; Viguier, M.; Valois, A.; Kupfer‐Bessaguet, I.; Goronflot... Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Reasons for discontinuation of dupilumab in adult atopic dermatitis in clinical practice. (20th January 2022) Authors: Marniquet, M.‐E.; Seneschal, J.; Darrigade, A.‐S.; Staumont‐Sallé, D.; Jachiet, M.; Nosbaum, A.; Tauber, M.; Abasq, C.; Ferrier Le Bouedec, M.‐C.; Droitcourt, C.; Aubert, H.; Bernier, C.; Soria, A.; Raison‐Peyron, N.; Tétart, F.; Aubin, F.; Viguier, M.; Valois, A.; Kupfer‐Bessaguet, I.; Goronflot... Journal: British journal of dermatology Issue: Volume 186:Number 4(2022) Page Start: 733 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗